October 25, 2020 17:58 | About us
Language: Tiếng Việt | ພາ​ສາ​ລາວ | ខ្មែរ | русский | 中文
Vaccine production: a billion-dollar industry

Vaccine production: a billion-dollar industry

16:00 | 14/08/2020

According to estimates of research firm Alliance Bernstein (headquarter in the US), the global vaccine production industry is worth $ 52 billion per year. In which, 4 developers including Sanofi, Merk, Pfizer and GlaxoSmithKline accounted for 85% of the market share.

A landmark partnership announced for development of COVID-19 vaccine in the UK

A landmark partnership announced for development of COVID-19 vaccine in the UK

18:29 | 06/05/2020

The University of Oxford has announced an agreement with the UK-based global biopharmaceutical company AstraZeneca, headquarter in the UK and representative office in Vietnam, for the further development, large-scale manufacture and potential distribution of the COVID-19, ChAdOx1 nCoV-19 vaccine candidate currently being trialled by the University. 

Australian scientists test potential Covid-19 vaccines on ferrets

Australian scientists test potential Covid-19 vaccines on ferrets

17:17 | 02/04/2020

Researchers of Commonwealth Scientific and Industrial Research Organisation (CSIRO) in Australia have tested two potential coronavirus vaccines on ferrets to determine whether the vaccines may proceed to human trials on April 2, BBC reported. 

Coronavirus Vaccine: Global Competition

Coronavirus Vaccine: Global Competition

00:27 | 21/03/2020

The United States, China and Europe are battling to be the first finder a cure, bringing a nationalist element to a worldwide crisis that could have created a chance of favoring the winner's population and potentially gain the upper hand in dealing with the economic and geostrategic fallout from the crisis.

China claims that Coronavirus vaccine could be ready by April

China claims that Coronavirus vaccine could be ready by April

21:07 | 15/03/2020

China has said that some vaccines for the novel coronavirus could be in clinical use next month as the number of global coronavirus cases soared past 100,000.  Zheng Zhongwei, director of the National Health Commission’s Science and Technology Development Center, expressed his hope of the vaccines would enter clinical research or be of use in emergency situation in April.

Breakthrough for the COVID-19 vaccine in poultry, adaptable to humans

Breakthrough for the COVID-19 vaccine in poultry, adaptable to humans

20:36 | 07/03/2020

Researchers at the Miguel Institute, supported by the Ministry of Science and Technology, explain the research at a press conference. They claim the vaccine’s efficacy has been proven in preclinical trials, and that the virus in poultry has a high genetic identity to the human virus and can be adapted within three months for human testing.

    Prev         Next